RESUMO
This study has systematically investigated the types of drug delivery in the treatment and prevention of oral and dental and cardiorespiratory diseases in patients and animals involved in the disease. Early recognition of risk factors and primary prevention significantly reduces complications and mortality in chronic heart diseases. Lifestyle modification with diet, exercise and smoking cessation is very important to reduce cardiovascular risk factors. In the first days of the disease, when the patient has mild symptoms and has not yet developed respiratory symptoms, you can start treatment with painkillers for headache, sore throat and body pain, along with taking antitussive medicine and vitamin D and C although scientifically the effect of vitamin C. It is not proven, but considering that we still do not have extensive studies on this disease, it seems that taking vitamins may help the patient. Sometimes, some patients themselves start treatment with azithromycin, while this antibiotic has an effect on antibacterial infections and has no effect on the disease of Covid-19. Favipiravir treatment should be started in high-risk outpatients with corona. Of course, along with treatment with favipiravir and similar antiviral effects, it can be effective in the treatment of corona. Famotidine and melatonin, which help improve sleep and are said to have antiviral effects. Of course, melatonin medicine should be taken at around 11 to 12 at night. Because it affects the sleep and wake cycle. Montelukast along with fexofenadine, can have antiviral effects for covid-19 patients. Since the beginning of the Corona pandemic, the world has emphasized on the monthly consumption of vitamin D, but if you do not have a monthly intake, use 1000 milligrams daily or up to 50 thousand units every week and after some time continue to consume vitamin D on a monthly basis. It is also recommended to take vitamin C and magnesium, and it is better for patients to eat foods rich in protein, potassium, and dairy products.
RESUMO
This systematic review of scientific sources (190 articles) shows that the simultaneous presence of cardio-metabolic, dental, as well as neurologic diseases is common in people who are hospitalized due to COVID-19 infection, and cardiovascular complications occur frequently. Many people with COVID-19 have few or no symptoms. However, COVID-19 can make the blood "sticky," blocking both small (capillaries) and large blood vessels, which may cause 1 heart attacks, strokes, or blood clots in the legs or lungs. People with diabetes, high blood pressure, or pre-existing heart problems are at higher risk of developing such complications if they get COVID-19. A total of 190 studies reported relevant information. Further studies were conducted in China and the United States of America. The results show that high blood pressure, diabetes and heart disease are very common in hospitalized patients with COVID-19 and are associated with an increased risk of mortality. More than a third of patients with COVID-19 had a history of high blood pressure, 23.4% of them mentioned a previous heart or blood vessel problem, 30.4% had diabetes, and 14.6% were obese.
RESUMO
This study has done a systematic review of drug therapy and assessment of the occurrence of dental and neurological problems in patients affected by covid-19. There are various reasons that can cause an infection in the tooth. One of the most common causes of tooth infection is root canal treatments you have had in the past. Unfortunately, bacteria grow in this area and can lead to infection. Having an infection in the tooth can be very dangerous. Because it may spread to other parts of the body and cause serious problems. For this reason, it is very important to recognize the symptoms of infection. When a crack or cavity is formed on the tooth, if not treated in time, an infection may occur in the tooth. Because these are the gates that can pave the way for bacteria to enter your teeth. The most common type of disease is accompanied by episodes of severe pain that may be felt in the eyes, ears, lips, nose, forehead, cheeks, teeth or jaws, or anywhere on the face. The similarity of the symptoms of this complication with the symptoms of common dental diseases is a factor in misdiagnosis. This can lead to a series of unnecessary dental treatments that not only won't solve the problem, but may actually make it worse. Some patients undergo dental treatment at least once before the diagnosis of the disease. 1.
RESUMO
This study has focused on the systematic investigation of radiological signs and drug delivery in patients affected by Covid-19. Researchers believe that the pneumonia caused by the infection of Covid-19 (NCIP) started from the seafood market in Wuhan, by the time this article was published, the coronavirus had spread in 28 countries. Evidence shows that the transmission of the corona virus can occur during the epidemic period. The incubation period of the disease is the period of time when a person is unaware of his disease, but is a carrier of the disease. The incubation period of the new corona virus, Covid-19, is estimated to be about 5.2 days. This has caused the rapid spread of the coronavirus disease. Also, after recovering from this disease for some time, there is a possibility of transmission of the disease through the saliva of a patient with NCIP. Since February 5, 2020, more than 25,000 cases of corona virus have been reported and the number of dead patients is increasing. Medical imaging plays an important role in assessing the severity of the Covid-19 infection. Radiologists should be well aware of the imaging findings of this novel coronavirus. Evidence also suggests that chest CT and ultrasound are better at differentiating COVID-19 infection from other respiratory problems. Its usefulness may therefore be limited to ruling out COVID-19 infection rather than distinguishing it from other causes of lung infection. In addition, chest CT imaging had poor sensitivity and high specificity for detecting asymptomatic individuals.